The NIH-funded Polygenic Risk Methods in Diverse Populations (PRIMED) Consortium is developing and evaluating methods to improve the use of polygenic risk scores (PRS) to predict disease and health outcomes in diverse ancestry populations.
For Researchers
Learn more about PRIMED Consortium research and ways to get involved.
For Consortium Members
Visit your customized dashboard to view consortium information.
News and Publications

The NIH will fund grants totaling $38 million over five years to develop methods that will improve the way that polygenic risk scores can be used to predict disease in diverse communities.
Read more

Association of prostate-specific antigen levels with prostate cancer risk in a multiethnic population: Stability over time and comparison with polygenic risk score. Cancer Epidemiology, Biomarkers & Prevention.
Polygenic Risk Scores for Prediction of Breast Cancer in Korean women. International Journal of Epidemiology.
See more